Publications

5674 Results

The relationship of gleason sum and survival in patients with metastatic (M+) prostate cancer (CaP): analysis of SWOG 8894.

Authors
ED Crawford;G Miller;J Faulkner;C Tangen;IM Thompson;M Eisenberger;M Hussain
Journal / Conference
South Central Section of the AUA, 81st Annual Meetings :170(#31)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

HRQL outcomes in a phase II trial for patients with recurrent ovarian cancer: was palliation achieved?

Authors
CM Moinpour;B Lyons;S McCoy;GL Winakur;PY Liu;ML Rothenberg
Journal / Conference
Quality of Life Research 11(7):660(#157)
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9324

Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.

Authors
SA Hundahl;JS Macdonald;J Benedetti;T Fitzsimmons
Journal / Conference
Annals of Surgical Oncology 9(3):278-286
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Bayesian cure rate models for malignant melanoma: a case-study of Eastern Cooperative Oncology Group trial E1690

Authors
MH Chen;DP Harrington;JG Ibrahim
Journal / Conference
Applied Statistics 51(part.2):135-150
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of Intergroup 0114

Authors
JE Tepper;M O'Connell;D Niedzwiecki;DR Hollis;AB Benson III;B Cummings;LL Gunderson;JS Macdonald;JA Martenson;RJ Mayer
Journal / Conference
Journal of Clinical Oncology 20(7):1744-1750
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9040

Editorial: How does interferon work? does it even matter?

Authors
VK Sondak
Journal / Conference
Cancer 95(5):947-949
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9325 (EST-2690)

The influence of gender on survival and tumor recurrence following adjuvant therapy of cmopletely resected stages II and IIIa non-small cell lung cancer.

Authors
SM Keller;MG Vangel;S Adak;H Wagner;JH Schiller;A Herskovic;R Komaki;MC Perry;RS Marks;RB Livingston;DH Johnson
Journal / Conference
Lung Cancer 37:303-309
Year
2002
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)

Letter to the editor: Interferon alfa-2a for melanoma metastases

Authors
Jm Kirkwood;JG Ibrahim;VK Sondak;MS Ernstoff;M Ross
Journal / Conference
The Lancet 359:978-979
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690), SWOG-9512 (E1694)

Surgical quality in trials of adjuvant cancer therapy

Authors
SA Hundahl
Journal / Conference
Journal of Surgical Oncology 80:177-180
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Outcomes and toxicity in African-American and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

Authors
AD McCollum;PJ Catalano;DG Haller;RJ Mayer;JS Macdonald;AB Benson III;CS Fuchs
Journal / Conference
Journal of the National Cancer Institute 94(15):1160-1167
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)